Pharma News

More than 900 staff members in the Mayo Clinic Health System in the Midwest have been diagnosed with COVID-19 over the last two weeks as the virus continues to surge across the region, officials said.

Pfizer Inc.

CHICAGO, Nov.

The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has "no important effect" on survival chances, the World Health Organiza...

An experimental Alzheimer's disease treatment is proving effective at treating some of the most persistent, life-threatening antibiotic-resistant bacteria.

Doubling its Series B raise last year, clinical-stage pharmaceutical company Imago Biosciences raked in $80 million this week to take their lead candidate through a Phase III trial.

LONDON — The coronavirus vaccine being developed by the University of Oxford and AstraZeneca could still be made available at a similar time to the other leading candidates, according to the head of...

Amazon has been quietly building out its pharmacy offering for several years after ramping up internal discussions in 2017 and acquiring PillPack in 2018.

Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab.

As the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors have diverted their money to the sector.

A drug used to treat rheumatoid arthritis may reduce the risk of dying for elderly patients with Covid-19, and provide a new weapon in the arsenal against the novel coronavirus, according to a study.

AstraZeneca’s P2Y12 receptor antagonist Brilinta reduced the rate of stroke and death in a prespecified, high-risk subgroup, according to new analysis of the phase III THALES trial.